Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour.

Jones SE, van Hees VT, Mazzotti DR, Marques-Vidal P, Sabia S, van der Spek A, Dashti HS, Engmann J, Kocevska D, Tyrrell J, Beaumont RN, Hillsdon M, Ruth KS, Tuke MA, Yaghootkar H, Sharp SA, Ji Y, Harrison JW, Freathy RM, Murray A, Luik AI, Amin N, Lane JM, Saxena R, Rutter MK, Tiemeier H, Kutalik Z, Kumari M, Frayling TM, Weedon MN, Gehrman PR, Wood AR. · 2019

Read Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour. by Jones SE, van Hees VT, Mazzotti DR, Marques-Vidal P, Sabia S, van der Spek A, Dashti HS, Engmann J, Kocevska D, Tyrrell J, Beaumont RN, Hillsdon M, Ruth KS, Tuke MA, Yaghootkar H, Sharp SA, Ji Y, Harrison JW, Freathy RM, Murray A, Luik AI, Amin N, Lane JM, Saxena R, Rutter MK, Tiemeier H, Kutalik Z, Kumari M, Frayling TM, Weedon MN, Gehrman PR, Wood AR. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6451011.txt.

Introduction

Jones and co-authors hunt genes behind sleep behavior using wrist accelerometer records from 85,670 UK Biobank participants rather than questionnaires. Eight derived traits covered sleep quality, quantity, and timing, and findings were validated in 5,819 more people. Objective measurement avoids the distortions of self-report.

Forty-seven genetic associations passed the standard threshold, including 26 new ones for sleep quality and 10 for night-time duration. Most variants touched a single trait. A missense change in PDE11A stood out as the likely causal variant for duration, and sleep-quality loci clustered near serotonin-processing genes. Restless legs variants were a noted complication, since the condition can masquerade in movement data.

Catalog record

CREATORJones SE, van Hees VT, Mazzotti DR, Marques-Vidal P, Sabia S, van der Spek A, Dashti HS, Engmann J, Kocevska D, Tyrrell J, Beaumont RN, Hillsdon M, Ruth KS, Tuke MA, Yaghootkar H, Sharp SA, Ji Y, Harrison JW, Freathy RM, Murray A, Luik AI, Amin N, Lane JM, Saxena R, Rutter MK, Tiemeier H, Kutalik Z, Kumari M, Frayling TM, Weedon MN, Gehrman PR, Wood AR.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6451011

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour By Samuel E. Jones, Vincent T. van Hees, Diego R. Mazzotti, Pedro Marques-Vidal, Séverine Sabia, Ashley van der Spek, Hassan S. Dashti, Jorgen Engmann, Desana Kocevska, Jessica Tyrrell, Robin N. Beaumont, Melvyn Hillsdon Published in: Nature Communications DOI: 10.1038/s41467-019-09576-1 ABSTRACT Sleep is an essential human function but its regulation is poorly understood. Using accelerometer data from 85,670 UK Biobank participants, we perform a genome-wide association study of 8 derived sleep traits representing sleep quality, quantity and timing, and validate our findings in 5,819 individuals. We identify 47 genetic associations at P < 5 × 10−8, of which 20 reach a stricter threshold of P < 8 × 10−10. These include 26 novel associations with measures of sleep quality and 10 with nocturnal sleep duration. The majority of identified variants associate with a single sleep trait, except for variants previously associated with restless legs syndrome. For sleep duration we identify a missense variant (p.Tyr727Cys) in PDE11A as the likely causal variant. As a group, sleep quality loci are enriched for serotonin processing genes. Although accelerometer-derived measures of sleep are imperfect and may be affected by restless legs syndrome, these findings provide new biological insights into sleep compared to previous efforts based on self-report sleep measures. INTRODUCTION Sleep is an important human function, but many aspects of the mechanisms that regulate it remain poorly understood. Adequate sleep is important for health and wellbeing, and changes in sleep quality, quantity and timing are strongly associated with several human diseases and psychiatric disorders1–5. Identifying genetic variants influencing sleep traits will provide new insights into the molecular regulation of sleep in humans and help to establish the genetic contribution to causal links between sleep and associated chronic diseases, such as diabetes and obesity6–10. Genome-wide association studies (GWAS) are an important first step towards the discovery of new biological mechanisms of complex traits. Previous large-scale genetic studies of sleep traits have relied on self-reported measures. For example, using questionnaire data from 47,180 individuals, the CHARGE consortium identified the first common genetic variant, near PAX8, robustly associated with sleep duration11. Subsequent studies in up to 128,286 individuals using the interim data release of the UK Biobank identified two additional sleep duration loci12,13 and a parallel analysis of the full UK Biobank release of 446,118 individuals identified a total of 78 associated loci14. Genetic associations have also been identified for other self-reported sleep traits, including chronotype12,15,16, insomnia, and daytime sleepiness13,17–21. Although the reported associations revealed relevant pathways related to mechanisms underlying sleep regulation, in large-scale studies self-report measures are typically based on a limited number of questions that only approximate a limited number of sleep traits and may be subject to bias related to an individual’s perception and recall of sleeping patterns22–26. Polysomnography (PSG) is regarded as the gold standard method of quantifying nocturnal sleep traits, but it is impractical to perform in large cohorts. Additionally, PSG is relatively burdensome, since it involves the use of complex equipment and experimental settings to represent individual’s habitual sleep, making it less suitable for measuring sleep over multiple nights and capturing inter-daily variability. By contrast, research-grade activity monitors (accelerometers), also known as actigraphy devices, are more objective and may provide cost-effective estimates of sleep for large studies. To date, studies of limited sample size have been performed and focussed on daytime activity27,28. The UK Biobank study is a unique resource collecting vast amounts of clinical, biomarker, and questionnaire data on ~500,000 UK residents. Of these, 103,000 participants wore activity monitors continuously for up to 7 days. This provides an opportunity to derive accelerometer-based estimates of sleep quality, quantity and timing and to assess the genetics of sleep traits. In this study, we identify genetic variants associated with accelerometer-derived measures of sleep and rest-activity patterns and use them to further understand the biology of sleep. We use accelerometer data from the UK Biobank to extract estimates of sleep characteristics using a heuristic method previously compared against independent PSG and sleep-diary datasets. These estimates have previously been demonstrated to be correlated with polysomnography and sleep diaries29,30. We analyse a total of eight accelerometer-based measures of sleep and activity timing. These include measures representative of sleep quality, including sleep efficiency (sleep duration divided by the time between the start and end of the first and last nocturnal inactivity period, respectively) and the number of nocturnal sleep episodes. In addition, we derive measures of timing (sleep midpoint, timing of the least-active 5 h (L5), and timing of the most-active 10 h (M10)), and duration (diurnal inactivity and nocturnal sleep duration and variability). We present a GWAS in 85,670 UK Biobank participants and validate our findings in three independent studies. Our analysis primarily focuses on traits that cannot be captured, or are unavailable, from self-report sleep measures, and are likely to be underpowered for GWAS in studies with PSG data due to limited sample sizes. RESULTS Sleep quality and quantity are uncorrelated with timing Descriptive statistics and correlations between the eight accelerometer-derived phenotypes are shown in Table 1 and Supplementary Table 1. We observed little phenotypic correlation (R) between measures of sleep timing and measures of nocturnal sleep duration and quality (−0.10 ≤ R ≤ 0.12). These negligible or limited correlations between timing and duration are consistent with data from self-reported chronotype and sleep duration (R = −0.01). We also observed limited correlation between sleep duration and sleep quality as represented by the number of nocturnal sleep episodes (R = 0.14) but observed a stronger correlation between sleep duration and sleep efficiency (R = 0.57). The correlations between self-reported sleep duration and accelerometer-derived sleep duration was 0.19 and between self-reported chronotype (morningness) and L5 timing was −0.29.Table 1Descriptive statistics of sleep and activity measures derived from accelerometer dataMeasureMeanS.D.MinMax N L5 timing (hours from previous midnight)27.321.0712.2935.3585,830M10 timing (hours from previous midnight)13.701.210.2623.4485,723Sleep midpoint (hours from previous midnight)26.990.9116.2531.9885,502Sleep duration mean (hours)7.300.863.0011.8785,502Sleep duration (SD; (hours))0.930.570.007.2685,068Sleep efficiency (%)76.187.1828.74100.0085,502Number of sleep episodes17.253.595.1429.8685,502Diurnal inactivity duration0.970.6809.2185,502Units for the midpoint of the least-active 5 h (L5), midpoint of most-active 10 h (M10), sleep duration, sleep duration variation (SD), sleep midpoint and diurnal inactivity are in hours. Sleep efficiency is a ratio and number of sleep episodes is a count Accelerometer-derived sleep pattern estimates are heritable To estimate the proportion of variance attributable to genetic factors for a given trait, we used BOLT-REML to estimate SNP-based heritability (h2SNP) (Table 2). The h2SNP estimates ranged from 2.8% (95% CI 2.0%, 3.6%) for variation in sleep duration (defined as the standard deviation of accelerometer-derived sleep duration across all nights), to 22.3% (95% CI 21.5%, 23.1%) for number of nocturnal sleep episodes. For sleep duration, we observed higher heritability using the accelerometer-derived measure (h2SNP = 19.0%, 95% CI 18.2%, 19.8%) in comparison to self-report sleep duration (h2SNP = 8.8%, 95% CI 8.6%, 9.0%). The heritability estimates for sleep and activity timings (maximum h2SNP = 11.7%, 95% CI 10.9%, 12.5%) were lower than for self-report chronotype (h2SNP = 13.7%, 95% CI 13.3%, 14.0%)31.Table 2Heritability estimates of derived sleep variables from BOLT-REMLSleep variable h 2 95% CISleep duration0.1900.182–0.198Sleep duration variability (SD)0.0280.020–0.036Number of nocturnal sleep episodes0.2230.215–0.231Sleep efficiency0.1300.122–0.138L5 timing0.1170.109–0.125M10 timing0.0870.079–0.095Sleep midpoint timing0.1010.093–0.109Diurnal inactivity0.1480.134–0.161 Low genetic correlation between sleep duration estimates

Read the complete text